Skip to main content

Articles

Practice Management
The Health and Economic Effects of Counterfeit Drugs
Stakeholder Perspective
The Hidden Market of Counterfeit Drugs a Concern for All Stakeholders
Read More
Conference Highlights AMCP
Pharmacy Management and Health Economics Outcomes
Read More
Perspectives
2014: The Year of the Healthcare Consumer
Read More
Original Research
Salsalate, an Old, Inexpensive Drug with Potential New Indications: A Review of the Evidence from 3 Recent Studies
Stakeholder Perspective
Considering Salsalate Use in Patients at Risk for Diabetes
Read More
Practice Management
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Stakeholder Perspective
The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden
Read More
Practice Management
The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature
Stakeholder Perspective
The Value of Pharmaceuticals in the Prevention and Treatment of CINV
Read More
Introduction
Cancer Care in 2014: Continuing Challenges, New Opportunities
Read More
Original Research
Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population
Stakeholder Perspective
Treatment Decisions in the Management of Malignant Gliomas
Read More
Perspectives
Payers’ Management of Oncology Drugs: Opportunities and Challenges
Read More
Perspectives
Where Is the Fix?
Read More
Page 149 of 244
Results 1481 - 1490 of 2434